For MDA5, although Egger’s test showed significant publication bias, the trim-and-fill method indicated no change in the results after adjustment, suggesting high credibility that the MDA5 antibody is a significant risk factor for RP-ILD. Here, IFIH1 is linked to interstitial lung disease.